2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Ligand Pharmaceuticals Inc | 10% Owner | 3,127,868 | Jul 3, 2025 |
| Goldman Sachs Group Inc | — | 686,330 | Feb 14, 2020 |
| Goldman Sachs & Co. Llc | — | 686,330 | Feb 14, 2020 |
| Higgins John L | CEO | 417,695 | Dec 30, 2022 |
| Davis Todd C | CEO | 161,467 | Jul 2, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6, 2026 | Reardon Andrew | CLO & Secretary | Sell | 23.8 | -5,000 | -11.94% | ✓ | $1M |
| Mar 4, 2026 | Mar 6, 2026 | Espinoza Octavio | CFO | Sell | 8.8 | -13,423 | -38.26% | ✓ | $2.8M |
| Mar 3, 2026 | Mar 5, 2026 | Sabba Stephen L | Director | Sell | 20.0 | -2,034 | -5.68% | ✗ | $409.9K |
| Mar 2, 2026 | Mar 4, 2026 | KOZARICH JOHN W | Director | Sell | 46.3 | -467 | -1.08% | ✓ | $93.6K |
| Feb 14, 2026 | Feb 18, 2026 | Reardon Andrew | CLO & Secretary | Sell | 100.0 | +6,058 | 19.66% | ✗ | $1.8M |
| Feb 14, 2026 | Feb 18, 2026 | Espinoza Octavio | CFO | Sell | 100.0 | +4,437 | 15.53% | ✗ | $2.2M |
| Feb 14, 2026 | Feb 18, 2026 | Davis Todd C | CEO | Sell | 100.0 | +27,549 | 17.08% | ✗ | $6M |
| Feb 2, 2026 | Feb 4, 2026 | KOZARICH JOHN W | Director | Sell | 46.3 | -467 | -1.07% | ✓ | $91.5K |
| Jan 2, 2026 | Jan 6, 2026 | KOZARICH JOHN W | Director | Sell | 46.3 | -467 | -1.06% | ✓ | $88.5K |
| Dec 31, 2025 | Jan 6, 2026 | Espinoza Octavio | CFO | Buy | 47.5 | +8 | 0.03% | ✗ | $765.4 |
| Dec 16, 2025 | Dec 18, 2025 | Espinoza Octavio | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2025 | Dec 16, 2025 | Espinoza Octavio | CFO | Sell | 20.0 | -1,804 | -6.45% | ✗ | $339.7K |
| Dec 5, 2025 | Dec 9, 2025 | Espinoza Octavio | CFO | Sell | 20.0 | -1,862 | -6.24% | ✗ | $344.2K |
| Dec 8, 2025 | Dec 8, 2025 | Aryeh Jason | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 4, 2025 | Dec 8, 2025 | Davis Todd C | CEO | Neutral | 52.5 | -130 | -0.08% | ✗ | - |
| Dec 1, 2025 | Dec 3, 2025 | KOZARICH JOHN W | Director | Sell | 45.0 | -467 | -1.05% | ✓ | $91.5K |
| Nov 7, 2025 | Nov 12, 2025 | Gray Nancy Ryan | Director | Sell | 17.5 | -6,571 | -28.87% | ✗ | $1.4M |
| Nov 7, 2025 | Nov 12, 2025 | LAMATTINA JOHN L | Director | Sell | 20.0 | -4,179 | -6.37% | ✗ | $858.6K |
| Nov 3, 2025 | Nov 5, 2025 | KOZARICH JOHN W | Director | Sell | 45.0 | -467 | -1.04% | ✓ | $89.2K |
| Oct 1, 2025 | Oct 3, 2025 | KOZARICH JOHN W | Director | Sell | 45.0 | -467 | -1.03% | ✓ | $83.8K |
| Sep 2, 2025 | Sep 4, 2025 | KOZARICH JOHN W | Director | Sell | 45.0 | -467 | -1.02% | ✓ | $75.8K |
| Aug 10, 2025 | Aug 12, 2025 | Reardon Andrew | CLO & Secretary | Sell | 22.5 | -1,325 | -4.12% | ✗ | $198.8K |
| Aug 1, 2025 | Aug 5, 2025 | KOZARICH JOHN W | Director | Sell | 45.0 | -467 | -1.01% | ✓ | $61.6K |
| Jul 10, 2025 | Jul 11, 2025 | KOZARICH JOHN W | Director | Sell | 45.0 | -934 | -1.97% | ✓ | $116.8K |
| Jul 1, 2025 | Jul 3, 2025 | LIGAND PHARMACEUTICALS INC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 3, 2025 | LIGAND PHARMACEUTICALS INC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 30, 2025 | Jul 2, 2025 | Reardon Andrew | CLO & Secretary | Buy | 68.8 | +233 | 0.73% | ✗ | $21.2K |
| Jun 30, 2025 | Jul 2, 2025 | Espinoza Octavio | CFO | Buy | 68.8 | +224 | 0.76% | ✗ | $20.4K |
| Jun 30, 2025 | Jul 2, 2025 | Davis Todd C | CEO | Buy | 56.3 | +233 | 0.14% | ✗ | $21.2K |
| Jun 23, 2025 | Jun 24, 2025 | Reardon Andrew | CLO & Secretary | Sell | 22.5 | -500 | -1.54% | ✗ | $57K |
| Jun 10, 2025 | Jun 12, 2025 | Reardon Andrew | CLO & Secretary | Sell | 22.5 | -500 | -1.52% | ✗ | $57.3K |
| Jun 6, 2025 | Jun 10, 2025 | Gray Nancy Ryan | Director | Neutral | 90.0 | +1,209 | 17.56% | ✗ | - |
| Jun 6, 2025 | Jun 10, 2025 | Aryeh Jason | Director | Neutral | 67.5 | +1,209 | 0.90% | ✗ | - |
| Jun 6, 2025 | Jun 10, 2025 | LAMATTINA JOHN L | Director | Neutral | 82.5 | +1,209 | 4.10% | ✗ | - |
| Jun 6, 2025 | Jun 10, 2025 | Zimmermann Martine | Director | Sell | 91.3 | +1,021 | 28.87% | ✗ | $19.9K |
| Jun 6, 2025 | Jun 10, 2025 | Sabba Stephen L | Director | Neutral | 82.5 | +1,209 | 3.71% | ✗ | - |
| Jun 6, 2025 | Jun 10, 2025 | KOZARICH JOHN W | Director | Neutral | 82.5 | +1,209 | 2.62% | ✗ | - |
| Jun 6, 2025 | Jun 10, 2025 | Haas Jason | Director | Neutral | 90.0 | +1,209 | 22.40% | ✗ | - |
| Aug 10, 2024 | Jun 2, 2025 | Reardon Andrew | CLO & Secretary | Sell | 22.5 | -1,897 | -3.36% | ✗ | $193.8K |
| Jan 17, 2025 | Jun 2, 2025 | KOZARICH JOHN W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 9, 2025 | May 13, 2025 | Davis Todd C | CEO | Buy | 95.0 | +9,510 | 6.27% | ✗ | $1M |
| May 9, 2025 | May 13, 2025 | Espinoza Octavio | CFO | Buy | 90.0 | +1,500 | 5.67% | ✗ | $156.1K |
| Apr 1, 2025 | Apr 16, 2025 | Sabba Stephen L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 4, 2025 | Mar 6, 2025 | Reardon Andrew | CLO & Secretary | Neutral | 90.0 | +6,415 | 22.61% | ✗ | - |
| Mar 4, 2025 | Mar 6, 2025 | Espinoza Octavio | CFO | Sell | 97.5 | +2,484 | 10.40% | ✗ | $575.1K |
| Mar 4, 2025 | Mar 6, 2025 | Davis Todd C | CEO | Neutral | 90.0 | +21,382 | 16.40% | ✗ | - |
| Feb 14, 2025 | Feb 19, 2025 | Davis Todd C | CEO | Sell | 95.0 | +7,332 | 5.96% | ✗ | $1.6M |
| Feb 14, 2025 | Feb 19, 2025 | Espinoza Octavio | CFO | Sell | 100.0 | +3,232 | 15.65% | ✗ | $1.2M |
| Feb 14, 2025 | Feb 19, 2025 | Reardon Andrew | CLO & Secretary | Sell | 97.5 | +5,834 | 25.89% | ✗ | $782.8K |
| Dec 23, 2024 | Dec 26, 2024 | Espinoza Octavio | CFO | Sell | 22.5 | -2,104 | -9.25% | ✗ | $244.9K |
| Dec 5, 2024 | Dec 6, 2024 | Espinoza Octavio | CFO | Sell | 22.5 | -1,859 | -7.55% | ✗ | $229.6K |
| Nov 27, 2024 | Dec 2, 2024 | LAMATTINA JOHN L | Director | Sell | 20.0 | -2,406 | -7.54% | ✗ | $297.5K |
| Sep 23, 2024 | Sep 25, 2024 | Reardon Andrew | CLO & Secretary | Sell | 22.5 | -2,000 | -8.15% | ✗ | $199.2K |
| Sep 20, 2024 | Sep 24, 2024 | Espinoza Octavio | CFO | Sell | 22.5 | -1,275 | -4.93% | ✗ | $132.5K |
| Sep 20, 2024 | Sep 24, 2024 | Korenberg Matthew E | COO | Sell | 17.5 | -16,047 | -7.08% | ✗ | $1.6M |
| Sep 17, 2024 | Sep 19, 2024 | Espinoza Octavio | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 16, 2024 | Sep 18, 2024 | Korenberg Matthew E | COO | Sell | 20.0 | -3,214 | -1.56% | ✗ | $337.5K |
| Aug 28, 2024 | Aug 30, 2024 | Espinoza Octavio | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 28, 2024 | Aug 30, 2024 | Reardon Andrew | CLO & Secretary | Sell | 22.5 | -1,500 | -6.24% | ✗ | $159.6K |
| Aug 22, 2024 | Aug 26, 2024 | Korenberg Matthew E | COO | Sell | 17.5 | -18,858 | -27.58% | ✗ | $2M |
| Aug 9, 2024 | Aug 13, 2024 | Korenberg Matthew E | COO | Sell | 17.5 | -18,245 | -21.06% | ✗ | $1.8M |
| Aug 8, 2024 | Aug 9, 2024 | Davis Todd C | CEO | Buy | 82.5 | +2,500 | 2.07% | ✗ | $243.5K |
| Jun 28, 2024 | Jul 2, 2024 | Reardon Andrew | Chief Legal Officer & | Buy | 78.8 | +329 | 1.48% | ✗ | $20K |
| Jun 28, 2024 | Jul 2, 2024 | Korenberg Matthew E | COO | Buy | 61.3 | +350 | 0.41% | ✗ | $21.2K |
| Jun 28, 2024 | Jul 2, 2024 | Espinoza Octavio | CFO | Buy | 78.8 | +267 | 1.14% | ✗ | $16.2K |
| Jun 28, 2024 | Jul 2, 2024 | Davis Todd C | CEO | Buy | 61.3 | +350 | 0.29% | ✗ | $21.2K |
| Jun 14, 2024 | Jun 25, 2024 | Sabba Stephen L | Director | Neutral | 82.5 | +1,252 | 4.33% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Zimmermann Martine | Director | Neutral | 90.0 | +1,252 | 54.79% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | LAMATTINA JOHN L | Director | Neutral | 82.5 | +1,252 | 4.43% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | KOZARICH JOHN W | Director | Neutral | 82.5 | +1,252 | 2.94% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Haas Jason | Director | Neutral | 90.0 | +1,252 | 30.21% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Gray Nancy Ryan | Director | Neutral | 90.0 | +1,252 | 22.23% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Aryeh Jason | Director | Neutral | 67.5 | +1,252 | 0.94% | ✗ | - |
| May 9, 2024 | May 17, 2024 | Gray Nancy Ryan | Director | Sell | 22.5 | -934 | -14.22% | ✗ | $77.7K |
| May 15, 2024 | May 17, 2024 | Espinoza Octavio | CFO | Sell | 17.5 | -13,293 | -12.58% | ✗ | $1.1M |
| May 13, 2024 | May 15, 2024 | Korenberg Matthew E | COO | Sell | 17.5 | -17,598 | -16.94% | ✗ | $1.5M |
| May 9, 2024 | May 13, 2024 | Reardon Andrew | Chief Legal Officer & | Sell | 20.0 | -10,000 | -31.05% | ✗ | $830.4K |
| Apr 30, 2024 | May 2, 2024 | Aryeh Jason | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 24, 2024 | Apr 26, 2024 | KOZARICH JOHN W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 25, 2024 | Mar 27, 2024 | Davis Todd C | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 5, 2024 | Mar 7, 2024 | Sabba Stephen L | Director | Sell | 22.5 | -1,893 | -6.14% | ✗ | $140.6K |
| Mar 5, 2024 | Mar 6, 2024 | Aryeh Jason | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 27, 2024 | Feb 29, 2024 | Reardon Andrew | CHIEF LEGAL OFFICER & | Neutral | 90.0 | +7,208 | 48.06% | ✗ | - |
| Feb 27, 2024 | Feb 29, 2024 | Korenberg Matthew E | COO | Neutral | 90.0 | +14,416 | 16.12% | ✗ | - |
| Feb 27, 2024 | Feb 29, 2024 | Espinoza Octavio | CFO | Sell | 91.3 | +7,068 | 13.77% | ✗ | $12.4K |
| Feb 27, 2024 | Feb 29, 2024 | Davis Todd C | CEO | Neutral | 90.0 | +32,436 | 45.23% | ✗ | - |
| Feb 15, 2024 | Feb 16, 2024 | Reardon Andrew | CHIEF LEGAL OFFICER & | Sell | 26.3 | -593 | -3.80% | ✗ | $44.3K |
| Feb 15, 2024 | Feb 16, 2024 | Korenberg Matthew E | COO | Sell | 20.0 | -4,778 | -5.07% | ✗ | $356.7K |
| Feb 15, 2024 | Feb 16, 2024 | Espinoza Octavio | CFO | Sell | 22.5 | -1,479 | -6.46% | ✗ | $110.4K |
| Feb 15, 2024 | Feb 16, 2024 | Davis Todd C | CEO | Sell | 22.5 | -1,381 | -1.89% | ✗ | $103.1K |
| Dec 29, 2023 | Jan 4, 2024 | Reardon Andrew | CHIEF LEGAL OFFICER & | Buy | 78.8 | +179 | 1.16% | ✗ | $10.9K |
| Jan 2, 2024 | Jan 4, 2024 | Korenberg Matthew E | COO | Sell | 22.5 | -2,917 | -3.00% | ✗ | $210.9K |
| Dec 5, 2023 | Dec 6, 2023 | Espinoza Octavio | CFO | Sell | 22.5 | -1,269 | -5.25% | ✗ | $75.6K |
| Dec 5, 2023 | Dec 6, 2023 | Korenberg Matthew E | COO | Sell | 22.5 | -1,984 | -2.00% | ✗ | $118.3K |
| Oct 1, 2023 | Oct 3, 2023 | Espinoza Octavio | CFO | Sell | 26.3 | -346 | -1.41% | ✗ | $20.7K |
| Sep 22, 2023 | Sep 26, 2023 | Zimmermann Martine | Director | Neutral | 90.0 | +2,285 | 100.00% | ✗ | - |
| Sep 25, 2023 | Zimmermann Martine | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 22, 2023 | Sep 25, 2023 | Davis Todd C | CEO | Buy | 90.0 | +4,000 | 5.79% | ✗ | $237.5K |
| Aug 10, 2023 | Aug 14, 2023 | Reardon Andrew | CHIEF LEGAL OFFICER & | Sell | 22.5 | -897 | -5.50% | ✗ | $61.7K |
| Jun 30, 2023 | Jul 10, 2023 | Korenberg Matthew E | COO | Buy | 61.3 | +376 | 0.38% | ✗ | $21.3K |